Company intelligence / Profile preview

Rinri Therapeutics

Sheffield, South Yorkshire, United Kingdomrinri-therapeutics.com ↗
Ownership
Private
Employees
~30
Development stage
Preclinical
01

Overview

Rinri Therapeutics has developed a proprietary regenerative cell therapy platform targeting sensorineural hearing loss by replacing lost or damaged auditory neurons. Their lead candidate, Rincell‑1, demonstrated reversal of hearing loss and ~40% improvement in hearing threshold in preclinical models. The company has regulatory validation to begin first-in-human trials in the UK during 2025. Additional pipeline programs target alternative neuronal replacement strategies and hair cell regeneration.

Therapeutic areas
Neurology
Modalities
Regenerative cell therapy (stem cell-derived auditory neuron precursors)Pluripotent stem cells reprogrammed into auditory sensory cells
Industry
Biotech
02

Drug pipeline

3 assets

Rincell-1

2

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Rinri Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rinri Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call